Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Mylan to acquire Meda in US$9.9bn cash and stock deal

Will create a leading pharma firm with a portfolio of branded and generic medicines and a strong portfolio of over-the-counter products

Europe | Generics | Finance

LabConnect builds new biorepository in Johnson City, Tennessee

Has the capacity to offer absolute protection for more than eight million samples

North America

Packaging becomes lower volume but more complex

As the number of biological drugs increases, more careful consideration of packaging is required to ensure quality, safety and compliance. Susan Birks reports on the trends


Lonza signs manufacturing agreement with Renova Therapeutics for clinical supply of gene therapy treatment

Lonza will develop a cost-effective, scalable and robust suspension culture-based adenovirus manufacturing platform

North America | Therapeutic Sector | Cardiology

WHP completes bio-manufacturing facility for Oxford Biomedica

Additional cleanroom space took less than 12 months from concept to completion and creates extra capacity

Design and Build | Europe | Biotechnology | Production

Prefilled syringes: glass or polymer?

Prefilled syringes come in many varieties with the most fundamental difference being the material they are made of – glass or polymer. Manufacturer Schott considers how to make the right choice


The progress of serialisation in the US and beyond

Protecting patients from product fraud and tampering has become a major industry and regulatory initiative. Justin Schroeder, Executive Director Marketing, Business Development and Design, PCI Pharma Services, summarises progress and highlights some unresolved issues

Packaging | Regulatory

Biogen joins Centre for Therapeutic Target Validation to improve success rate for drug discovery

CTTV uses advances in genetic research and computational biology to help scientists with the crucial first step in exploring new medicines

Europe | North America | R and D | Biotechnology

Outsourcing goes from strength to strength

Predictions of healthy growth in pharma outsourcing in 2015 seem to have been fulfilled, but can the trend be sustained this year? The latest surveys from Nice Insight suggest it can, writes Nigel Walker, Managing Director, That’s Nice LLC/Nice Insight

R and D

EU considers endocrine disrupter controls

It has long been known that pharmaceutical residues can become hormone-affecting ‘endocrine disrupters’ when released into the environment and future controls are likely – but how will the legislators tackle the issue? Manufacturing Chemist reports

Europe | North America | Sustainability | Regulatory | Production

In the Press